RxDoctor Payments Data

John Koerner, MD

Orthopaedic Surgery of the Spine · Paramus, NJNPI 1427219914

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (51.7%), food and beverage and education — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Titan Spine, LLC at 39.0% of the total. Reporting peaked in 2019 at $2,708 and has fallen 85.9% since, to $383 in 2025. That places this record below the midpoint for orthopaedic surgery of the spine clinicians in NJ, where the typical reported total is $6,857.

$4,042in general payments, 2019–2025

Across 39 payments — averaging $103.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Titan Spine, LLC$2K
  • Globus Medical$1K
  • Stryker$370
  • Johnson & Johnson$254
  • Zimmer Biomet$205
  • Medtronic$171
  • plus $256 from 7 others

What the payments were for

  • Travel & lodging$2,08852%
  • Food & beverage$1,76644%
  • Education$1895%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,042 in reported general payments places this provider in the 35th percentile of 84 orthopaedic surgery of the spine providers in New Jersey.

See all orthopaedic surgery of the spine providers in New Jersey

Medicare billing

Part B allowed, 2024
$175,200
Medicare patients
343
Services billed
983

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin233$2,063
Pregabalin31$430
Celecoxib26$355
Methylprednisolone41$262
Tramadol Hcl14$113
Diazepam22$52
Meloxicam15$49

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Paramus

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →